SCHEMBL6411302

SCHEMBL6411302

O=C(NC1CCCC1OCc1ccccc1)OC1=NOC2(CCN(S(=O)(=O)c3ccc(F)cc3)CC2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.40
POLB P06746 1/20 0.39
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
PTGES O14684 3/20 0.37
PTGS2 P35354 3/20 0.37
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
SCN9A Q15858 2/20 0.37
SCN10A Q9Y5Y9 2/20 0.37
LMNA P02545 3/20 0.37
GAA P10253 3/20 0.37
HTT P42858 2/20 0.37
KCNA5 P22460 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6410443 0.93 MEN1 (0.41) P2RX7PKMTSHRPTGESPTGS2
SCHEMBL6409613 0.91 KCNA5 (0.48) PKMALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL2400825 0.88 POLB (0.41) P2RX7POLBPTGESPTGS2ALDH1A1
SCHEMBL6409402 0.88 KMT2A (0.42) P2RX7ALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL6411506 0.87 P2RX7 (0.41) P2RX7PTGESPTGS2ALDH1A1MAPT
SCHEMBL6413448 0.86 ALDH1A1 (0.42) P2RX7POLBPKMTSHRPTGES
SCHEMBL6411720 0.86 P2RX7 (0.40) P2RX7PTGESPTGS2ALDH1A1KCNA5
SCHEMBL6410884 0.85 LMNA (0.44) P2RX7TSHRPTGESPTGS2SMN1; SMN2
SCHEMBL2401891 0.81 MEN1 (0.42) P2RX7PTGESPTGS2ALDH1A1KCNA5
SCHEMBL2403325 0.79 KCNA5 (0.51) POLBPKMALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP disclosed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP disclosed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO disclosed